Navigation Links
XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
Date:12/13/2010

THOUSAND OAKS, Calif., Dec. 13, 3010 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced top-line results from a Phase 3 trial evaluating XGEVA™ (denosumab) versus placebo in 1,432 men with castrate-resistant prostate cancer. The trial, known as the '147 study, demonstrated that XGEVA significantly improved median bone metastasis-free survival by 4.2 months (HR=0.85, 95 percent CI 0.73-0.98, p=0.03) compared to placebo (primary endpoint), and significantly improved time to first occurrence of bone metastases (secondary endpoint). Overall survival was similar between the XGEVA and placebo groups (secondary endpoint).

Overall rates of adverse events and serious adverse events were generally similar between XGEVA and placebo, with hypocalcemia and osteonecrosis of the jaw (ONJ) observed at increased frequencies in the XGEVA arm.  The yearly rate of ONJ in the XGEVA-treated group was similar to what has been observed in prior XGEVA trials.  

"Our data demonstrate that XGEVA, which antagonizes the RANK Ligand axis, limits the ability of tumors to colonize bone, an important finding for men at risk for bone metastases and their healthcare providers," said Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen. "We look forward to presenting these landmark data at an upcoming medical conference."

The RANK Ligand pathway, first discovered by Amgen scientists in the mid-1990s, is believed to play a central role in cancer-induced bone destruction, regardless of cancer type. Data suggest that in bone metastasis, the invasion of cancer is facilitated by bone destruction. Hence, increased bone resorption due to increased RANK Ligand expression appears to augment bone metastasis.

XGEVA is a fully human monoclonal antibody that binds to RANK Ligand, a protein essential for the formation, function and
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
2. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
3. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
4. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
5. CyberKnife® VSI™ System Expands Treatment Applications and Significantly Reduces Treatment Times
6. Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
7. Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
8. Americans Confidence in Their Ability to Access and Pay for Healthcare Declines Significantly in May, According to Thomson Reuters Index
9. New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
10. Home Health Monitoring May Significantly Improve Blood Pressure Control, Kaiser Permanente Study Finds
11. Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The ... in Boston, MA on May 29, ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access Mr. ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)... KNOXVILLE, Tenn. , May 23, 2013 /PRNewswire/ ... of 24-hour nurse triage and nurse advice lines, ... 10-person committee, comprising physician, nursing and administrative leaders, ... providing safe, quality and cost-effective services for hospital ... "As our national healthcare system evolves, it,s imperative ...
(Date:5/23/2013)...  Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good chance ... Gionfriddo , about her now 20-month-old son, Kaiba. "At ... would take it and run with it." They ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... , , , , ... , THE WOODLANDS, Texas, July 21 ... biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, ... for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) for ...
... , TOKYO, July 21 R-Tech Ueno, Ltd. ... on the new compound RK-023 that is being developed by our ... see the note below) has been completed. , ... of a patch test (open, closed, photo-patch test), single-dose study and ...
Cached Medicine Technology:Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA 2Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA 3Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA 4R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 2R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 3
(Date:5/24/2013)... and Women,s Health Concern have today released updated guidelines ... the role of HRT, the benefits and the risks. ... Menopause International , published by SAGE. , ... being branded the "elixir of youth" to being considered ... circumstances. Since the publication of the Women,s Health Initiative ...
(Date:5/24/2013)... 24, 2013 Today marks the launch ... Itinerary Builder. , The redesigned and enhanced Itinerary ... vacation itineraries on their computer or mobile device that ... interactive tool allows users to fill in their date ... and select their choice of vacation packages, accommodations, restaurants, ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 DiaperBuys.com is ... Baby Photo Contest. Lindsey Willis of Olathe, Kansas, won ... from DiaperBuys. Second prize was a three-month supply ... North Las Vegas, Nev.; and third prize, a one-month ... The contest was run through the company’s Facebook page. ...
(Date:5/24/2013)... Wednesday, 15th May 2013 | 10am BST | ... webinar playback: http://bit.ly/10Rt0ZH , Ongoing regulatory changes are ... the globe and particularly in Europe, a number of these ... . For dealmakers, understanding how the likes of Basel iii, ... your corner of the market will give you a competitive ...
(Date:5/24/2013)... May 24, 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html ... the latest update involving allegations that the use ... (azithromycin) can allegedly cause potentially fatal irregular ... on May 17, 2013* that Health Canada has ... warning that Zithromax can cause abnormal changes in ...
Breaking Medicine News(10 mins):Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:DiaperBuys.com Announces Photo Contest Winners 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4
... ... management client since 1983, and Sturgis Hospital (Sturgis, Mich.), a management client since ... , ... Brentwood, Tenn. (PRWEB) December 17, 2009 -- Quorum Health Resources hospital clients Rutherford ...
... ... Open to primary care doctors who agree to BCBSNC’s standard contract. Physicians may qualify ... ... -- Blue Cross and Blue Shield of North Carolina (BCBSNC) is leading ...
... , VIRGINIA BEACH, Va., Dec. 17, ... 12 Hampton Roads-area non-profit organizations at its first ,Breakfast ... mistress of ceremonies was local television personality, Barbara Ciara, ... breakfast keynote speaker was world-renowned ,champion, and four-time heavyweight ...
... , MIAMI, Dec. 17 Physicians ... today announced that it has issued its financial statements ... are being posted today on the Pink Sheets (www.pinksheets.com). ... , Physicians Healthcare Management Group, Inc. (Phyhealth) is a ...
... glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) ... developing cancer. The results regarding the association between GSTM1 ... or CRC were contradictory. However, the majority of previous ... the association of the GSTM1/GSTT1 null genotype with the ...
... data, the molecular mechanism of infection employed by Salmonella ... the HZI research group "Cytoskeleton Dynamics". The group,s results have ... journal " Cellular Microbiology ". Salmonella are ... absence of oxygen and thus propagate in the gut. The ...
Cached Medicine News:Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 3Health News:The Amerigroup Foundation 'Breakfast of Champions' Honors Community Leaders with Boxing Champion Evander Holyfield 2Health News:The Amerigroup Foundation 'Breakfast of Champions' Honors Community Leaders with Boxing Champion Evander Holyfield 3Health News:Phyhealth Issues September 30, 2009 Financial Statements 2Health News:Invasion without a stir 2
... OXYPLETH is seven pounds of intelligent ... combined with software developed over 7 ... provides the ultimate in non-invasive oxygen ... oximeter monitor technology and sophisticated saturation ...
... The Models 512 and 513 ... processing. This advanced technology is able ... higher resolutions and speeds of 100 ... results in improved pulse oximeter performance ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... and 513 handheld pulse oximeters incorporate ... is able to process pulsatile signals ... of 100 times per second. This ... oximeter performance during motion or low ...
Medicine Products: